AIFA simplifies pricing and reimbursement procedure for biosimilars
The Italian Medicines Agency’s (AIFA) CTS and CPR Advisory Commissions have released a new simplified pricing and reimbursement procedure for … read more »
New executive order brings US IRP closer
President Trump has drawn further criticism from the pharmaceutical industry after signing another executive order aimed at bringing drug prices … read more »
*UPDATED* AIFA to launch consultation on P&R dossier requirements
AIFA (Agenzia Italiana del Farmaco, the Italian Medicines Agency) has announced an important consultation for the second half of September. … read more »
Japan may seek further pricing controls
A report has suggested that Japan’s concern over drug shortages may lead to a range of policies that include cost … read more »
China cuts drug prices through domestic competition
The world’s second biggest pharmaceutical market has slashed drug costs through opening certain categories of product to bidding by both … read more »
Italy’s reimbursement reforms leave questions
Reforms proposed in 2019, designed to relate Italian pricing and reimbursement decisions to the benefit offered by a medicine, have … read more »
Trump signs pricing orders
President Trump has followed through with a promise to use his Executive powers to bring new rules on pricing to … read more »
USA: Analysis shows States pushing ahead with pricing legislation
A new analysis by Deloitte has shown that States across America have been progressing various forms of drug pricing legislation, … read more »
Trump reported to be readying drug price executive orders
In a Fox News interview, President Trump’s Chief of Staff, Mark Meadows, revealed that three executive orders aimed at lowering … read more »
Companies lose pricing powers in Pakistan
Reports say that Prime Minister Imran Khan has instructed the Government to reform pharmaceutical pricing, removing the ability of companies … read more »
